atherogenesis

(redirected from atherogenicity)
Also found in: Dictionary, Thesaurus.

atherogenesis

 [ath″er-o-jen´ĕ-sis]
formation of abnormal fatty or lipid masses in arterial walls. adj., adj atherogen´ic.

ath·er·o·gen·e·sis

(ath'er-ō-jen'ĕ-sis),
Formation of atheroma, important in the pathogenesis of arteriosclerosis.

atherogenesis

(ăth′ər-ō-jĕn′ĭ-sĭs)
n.
Formation of atheromatous deposits, especially on the innermost layer of arterial walls.

ath′er·o·gen′ic (-jĕn′ĭk) adj.
ath′er·o·gen·i′ci·ty (-jə-nĭs′ĭ-tē) n.

ath·er·o·gen·e·sis

(ath'ĕr-ō-jen'ĕ-sis)
Formation of atheroma, important in the pathogenesis of arteriosclerosis.
References in periodicals archive ?
grandis at their optimum effective therapeutic doses exerted beneficial effects against dyslipidemia, atherogenicity, and oxidative stress in alloxan induced diabetic rats.
The thrombogenicity index and atherogenicity index were proposed by Ulbricht and Southgate (1991) with the aim of considering not only the family of fatty acids but also their biological effect.
Modified forms of LDL also possess proinflammatory properties and are prone to aggregation and formation of complexes that further increase their atherogenicity.
Authors used garlic powder in capsules for its effectiveness: six hours after the administration, the baseline rate of atherogenicity was three times lower.
The flavonoids, for example, may be potentially involved in such activity, by inhibiting the oxidation of LDL, reducing the atherogenicity, and consequently, the risk of coronary arterial disease.
(1,2) Inflammation results in increased oxidative stress and the release of reactive oxygen species (ROS), leading to oxidative damage to tissues and oxidative modification of lipoproteins, increasing their atherogenicity and contributing to atherosclerotic CVD.
New dimension of statin action on ApoB atherogenicity. Clin Cardiol.
The ability of blood serum to induce cholesterol accumulation is referred to as serum atherogenicity. It has been previously demonstrated that serum obtained from atherosclerosis patients caused cholesterol accumulation in cultured cells and therefore was highly atherogenic [81].
The nutritional quality index is estimated by several indices of fatty acid composition; the indices of atherogenicity (IA) and thrombogenicity (IT), according to Turan and coworkers [42], the hypocholesterolemic/hypercholesterolemic fatty acid ratio (HH) according to Testi and coworkers [40], EPA + DHA, PUFA/(SFA-stearic acid) according to Unusan [44], PUFA/SFA ratio according to Kalogeropoulos et al.